Skip to main content

Liver Disease News

FDA Approves Doptelet (avatrombopag) for Chronic Liver Disease Patients with Thrombocytopenia who are Undergoing a Medical Procedure

May 21, 2018 – The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are...

FDA Approves Cholbam (cholic acid) for Rare Bile Acid Synthesis Disorders

March 17, 2015 – Today the U.S. Food and Drug Administration approved Cholbam (cholic acid) capsules, the first FDA approved treatment for pediatric and adult patients with bile acid synthesis...

Ask a question

To post your own question to our community, sign in or create an account.